Targeting PDE3 Abrogates the Hallmarks of Asthma in Asthma Models
A. Kleinjan (Rotterdam, Netherlands), J. Beute (Rotterdam, Netherlands), K. Ganesh (Rotterdam, Netherlands), M. Lukkes (Rotterdam, Netherlands), M. Van Nimwegen (Rotterdam, Netherlands), S. Hockman (Bethesda, United States of America), V. Manganiello (Bethesda, United States of America), R. Hendriks (Rotterdam, Netherlands)
Source: International Congress 2018 – Tests and trends in asthma
Session: Tests and trends in asthma
Session type: Thematic Poster
Number: 3948
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Kleinjan (Rotterdam, Netherlands), J. Beute (Rotterdam, Netherlands), K. Ganesh (Rotterdam, Netherlands), M. Lukkes (Rotterdam, Netherlands), M. Van Nimwegen (Rotterdam, Netherlands), S. Hockman (Bethesda, United States of America), V. Manganiello (Bethesda, United States of America), R. Hendriks (Rotterdam, Netherlands). Targeting PDE3 Abrogates the Hallmarks of Asthma in Asthma Models. 3948
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: